Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immune System Diseases × Hydroxychloroquine × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 5 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Colorectal Neoplasms 3 Gastrointestinal Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Resectable 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Arthritis, Rheumatoid 1 Anatomic Stage I Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1

Interventions

Rituximab 3 Cyclophosphamide 3 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Etoposide 2 Doxorubicin 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 ibritumomab tiuxetan 1 fludarabine 1 cobomarsen 1 acalabrutinib 1 Melphalan 1 Lutetium 1 KW-2478 1 Imatinib Mesylate 1 Ifosfamide 1 Hsp90 inhibitor KU757 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡